Adult stem cells for cardiac tissue engineering.

Cell therapy and tissue engineering attract increasing attention as a potential approach for cardiac repair. Adult stem cells from autologous origin are a practically safe and appealing source for cell-based regenerative therapies that may hold realistic clinical potential. A plethora of interesting concepts have been introduced aiming at regenerating ischemic myocardium through adult stem cell-based bioartificial cardiac tissue supplements. Yet, current pre-clinical concepts have not reached translational applicability, and successes are only episodic. This review will provide a brief overview of the latest concepts and breakthroughs in the emerging field of cardiac adult stem cell-based tissue engineering, and discuses the challenges that this field needs to overcome to achieve realistic therapeutic translation into the clinical arena. This article is part of a special issue entitled, "Cardiovascular Stem Cells Revisited".

[1]  K. Fukuda.  Regeneration of cardiomyocytes from bone marrow: Use of mesenchymal stem cell for cardiovascular tissue engineering , 2003, Cytotechnology.

[2]  Giulio Cossu,et al.  Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart , 2004, Circulation research.

[3]  P. Boor,et al.  Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. , 2007, Journal of the American Society of Nephrology : JASN.

[4]  Z. Cui,et al.  Collagen–chitosan polymer as a scaffold for the proliferation of human adipose tissue-derived stem cells , 2009, Journal of materials science. Materials in medicine.

[5]  Jiyong Jin,et al.  Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model , 2009, European journal of heart failure.

[6]  S. Kitamura,et al.  Current address: Shinji Tomita, MD, Cardiothoracic Surgical Unit, Level 4, Auckland City Hospital, Auckland, New Zealand , 2005 .

[7]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[8]  Alain Carpentier,et al.  Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. , 2008, The Annals of thoracic surgery.

[9]  R. Kloner,et al.  Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium: Short- and Long-Term Effects , 2005, Circulation.

[10]  H. Drexler,et al.  Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial--an echocardiographic study. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[11]  E. Marbán,et al.  Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. , 2008, Heart rhythm.

[12]  V. Starnes,et al.  Migration of mesenchymal stem cells to heart allografts during chronic rejection , 2003, Transplantation.

[13]  R. Willemze,et al.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. , 2006, Blood.

[14]  K. P. Roos,et al.  Adipose tissue-derived cells improve cardiac function following myocardial infarction. , 2009, The Journal of surgical research.

[15]  Hao Zhang,et al.  Aging adversely impacts biological properties of human bone marrow-derived mesenchymal stem cells: implications for tissue engineering heart valve construction. , 2010, Artificial organs.

[16]  Pauline Chu,et al.  Imaging survival and function of transplanted cardiac resident stem cells. , 2009, Journal of the American College of Cardiology.

[17]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[18]  N. Bursac,et al.  Cardiac tissue engineering using stem cells [Cellular/Tissue Engineering] , 2009, IEEE Engineering in Medicine and Biology Magazine.

[19]  E. Guinan,et al.  Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation , 2003, Transplantation.

[20]  S. Verma,et al.  Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. , 2006, The Journal of clinical investigation.

[21]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[22]  C. Murry,et al.  Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. , 2002, Journal of molecular and cellular cardiology.

[23]  Larry Kedes,et al.  Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. , 2002, Journal of molecular and cellular cardiology.

[24]  Adam J. Engler,et al.  Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance , 2006 .

[25]  Sheng-Shou Hu,et al.  Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution. , 2007, The Journal of thoracic and cardiovascular surgery.

[26]  Hong Liu,et al.  A Tissue Engineering Approach to Progenitor Cell Delivery Results in Significant Cell Engraftment and Improved Myocardial Remodeling , 2007, Stem cells.

[27]  J. Leor,et al.  Cells, scaffolds, and molecules for myocardial tissue engineering. , 2005, Pharmacology & therapeutics.

[28]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[29]  A. Zeiher,et al.  Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  D. Mastroeni,et al.  Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. , 2010, Cardiovascular research.

[31]  D. Huso,et al.  Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. , 2005, Cytotherapy.

[32]  Yen Chang,et al.  Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. , 2008, Cardiovascular research.

[33]  Smadar Cohen,et al.  Myocardial Tissue Engineering: Creating a Muscle Patch for a Wounded Heart , 2004, Annals of the New York Academy of Sciences.

[34]  C. Bearzi,et al.  Human cardiac stem cells , 2005, Proceedings of the National Academy of Sciences.

[35]  T. Couffinhal,et al.  Repair of myocardial infarction by epicardial deposition of bone-marrow-cell-coated muscle patch in a murine model. , 2004, The Annals of thoracic surgery.

[36]  Li Deng,et al.  Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. , 2009, Biomaterials.

[37]  D. Bodine,et al.  Transplanted Adult Bone Marrow Cells Repair Myocardial Infarcts in Mice , 2001, Annals of the New York Academy of Sciences.

[38]  G. Noon,et al.  Cardiac transplantation: the final therapeutic option for the treatment of heart failure. , 2000, Current opinion in cardiology.

[39]  L. Pénicaud,et al.  Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells , 2004, Circulation research.

[40]  Federica Limana,et al.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Ganser,et al.  Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. , 2009, European heart journal.

[42]  Masayuki Yamato,et al.  Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. , 2006, Biochemical and biophysical research communications.

[43]  R. Kloner,et al.  Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. , 2009, Regenerative medicine.

[44]  Ming-Jium Shieh,et al.  The cardiomyogenic differentiation of rat mesenchymal stem cells on silk fibroin-polysaccharide cardiac patches in vitro. , 2009, Biomaterials.

[45]  D. Shum-Tim,et al.  Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. , 2006, The Journal of thoracic and cardiovascular surgery.

[46]  Yen Chang,et al.  Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction. , 2008, Cardiovascular research.

[47]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[48]  W. Hofmann,et al.  Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. , 2004, Journal of the American College of Cardiology.

[49]  D. Katritsis,et al.  Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[50]  Amit N. Patel,et al.  Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. , 2009, Frontiers in bioscience.

[51]  Bernd Hertenstein,et al.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial , 2004, The Lancet.

[52]  M. Cho,et al.  Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. , 2007, Biomaterials.

[53]  V. Lionetti,et al.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure , 2010, Heart Failure Reviews.

[54]  M. Penicka,et al.  Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. , 2007, American journal of physiology. Heart and circulatory physiology.

[55]  Ursula Ravens,et al.  Cardiac tissue engineering. , 2002, Transplant immunology.

[56]  S. Kitamura,et al.  Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[57]  A. Yousefi,et al.  Three‐dimensional porous scaffolds at the crossroads of tissue engineering and cell‐based gene therapy , 2009, Journal of cellular biochemistry.

[58]  I. Weissman,et al.  Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium , 2004, Nature.

[59]  A. Caplan.  Adult mesenchymal stem cells for tissue engineering versus regenerative medicine , 2007, Journal of cellular physiology.

[60]  J. Chachques.  Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure? , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[61]  T. Kofidis,et al.  Myocardial tissue engineering: the quest for the ideal myocardial substitute , 2009, Expert review of cardiovascular therapy.

[62]  L. Gepstein,et al.  Human Embryonic Stem Cells for Myocardial Regeneration , 2003, Heart Failure Reviews.

[63]  F. Mouquet,et al.  Restoration of Cardiac Progenitor Cells After Myocardial Infarction by Self-Proliferation and Selective Homing of Bone Marrow–Derived Stem Cells , 2005, Circulation research.

[64]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[65]  M. Burnett,et al.  Marrow-Derived Stromal Cells Express Genes Encoding a Broad Spectrum of Arteriogenic Cytokines and Promote In Vitro and In Vivo Arteriogenesis Through Paracrine Mechanisms , 2004, Circulation research.

[66]  H. Chiang,et al.  Porous acellular bovine pericardia seeded with mesenchymal stem cells as a patch to repair a myocardial defect in a syngeneic rat model. , 2006, Biomaterials.

[67]  Rutger-Jan Swijnenburg,et al.  Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[68]  W. Zimmermann,et al.  Embryonic stem cells for cardiac muscle engineering. , 2007, Trends in cardiovascular medicine.

[69]  K. Poh,et al.  Repeated direct endomyocardial transplantation of allogeneic mesenchymal stem cells: safety of a high dose, "off-the-shelf", cellular cardiomyoplasty strategy. , 2007, International journal of cardiology.

[70]  Yen Chang,et al.  Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. , 2008, Biomaterials.

[71]  Changyong Wang,et al.  Injectable cardiac tissue engineering for the treatment of myocardial infarction , 2010, Journal of cellular and molecular medicine.

[72]  M. Entman,et al.  Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. , 2001, The Journal of clinical investigation.

[73]  G. Dellgren,et al.  Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel , 2006, Annals of medicine.

[74]  S. Yuasa,et al.  Stem Cells as a Source of Regenerative Cardiomyocytes , 2006 .

[75]  T. Jensen,et al.  Adult human mesenchymal stem cell as a target for neoplastic transformation , 2004, Oncogene.

[76]  Gordana Vunjak-Novakovic,et al.  Percutaneous Cell Delivery into the Heart Using Hydrogels Polymerizing in Situ , 2009, Cell transplantation.

[77]  H. Ohgushi,et al.  Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy , 2005, Circulation.

[78]  Yu Suk Choi,et al.  Engineering cardiac tissue in vivo from human adipose-derived stem cells. , 2010, Biomaterials.

[79]  Seung‐Woo Cho,et al.  Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. , 2005, Biomaterials.

[80]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[81]  David M. Bodine,et al.  Bone marrow cells regenerate infarcted myocardium , 2001, Nature.

[82]  Myron Spector,et al.  Collagen-GAG scaffolds grafted onto myocardial infarcts in a rat model: a delivery vehicle for mesenchymal stem cells. , 2006, Tissue engineering.

[83]  M. Yamagishi,et al.  Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. , 2008, Biochemical and biophysical research communications.

[84]  David A. Williams,et al.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts , 2004, Nature.

[85]  Z. Cui,et al.  Adipose-derived stem cell: A better stem cell than BMSC , 2008, Cell Research.

[86]  T. Bartosh,et al.  3D‐model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress , 2008, Journal of cellular biochemistry.